Saad Alhumaid

4.5k total citations · 1 hit paper
77 papers, 2.2k citations indexed

About

Saad Alhumaid is a scholar working on Infectious Diseases, Epidemiology and Neurology. According to data from OpenAlex, Saad Alhumaid has authored 77 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 13 papers in Epidemiology and 12 papers in Neurology. Recurrent topics in Saad Alhumaid's work include SARS-CoV-2 and COVID-19 Research (28 papers), COVID-19 Clinical Research Studies (27 papers) and Long-Term Effects of COVID-19 (12 papers). Saad Alhumaid is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (28 papers), COVID-19 Clinical Research Studies (27 papers) and Long-Term Effects of COVID-19 (12 papers). Saad Alhumaid collaborates with scholars based in Saudi Arabia, Australia and Myanmar. Saad Alhumaid's co-authors include Ali A. Rabaan, Abbas Al Mutair, Kuldeep Dhama, Zainab Al Alawi, Manish Dhawan, Awad Al‐Omari, Talha Bin Emran, Jaffar A. Al‐Tawfiq, Saikat Mitra and Raghavendra Tirupathi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Saad Alhumaid

76 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies

2022 144 citations Kuldeep Dhama, Firzan Nainu et al. Journal of Infection and Public Health profile →

Peers

Saad Alhumaid

EPIDE

NEURO

AMB

Abbas Al Mutair Saudi Arabia

Laura Shallcross United Kingdom

Sanjat Kanjilal United States

Alberto Enrico Maraolo Italy

Ali S. Omrani Saudi Arabia

Salequl Islam Bangladesh

Gwenan M. Knight United Kingdom

Pasquale Pagliano Italy

Awad Al‐Omari Saudi Arabia

Satoshi Kutsuna Japan

Abbas Al Mutair Saudi Arabia

Saad Alhumaid

1.1k ×1.0

325 ×1.0

346 ×1.1

EPIDE

248 ×0.9

NEURO

247 ×1.0

AMB

Citations per year, relative to Saad Alhumaid Saad Alhumaid (= 1×) peers Abbas Al Mutair

Countries citing papers authored by Saad Alhumaid

Since Specialization

Citations

This map shows the geographic impact of Saad Alhumaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saad Alhumaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saad Alhumaid more than expected).

Fields of papers citing papers by Saad Alhumaid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saad Alhumaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saad Alhumaid. The network helps show where Saad Alhumaid may publish in the future.

Co-authorship network of co-authors of Saad Alhumaid

This figure shows the co-authorship network connecting the top 25 collaborators of Saad Alhumaid. A scholar is included among the top collaborators of Saad Alhumaid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saad Alhumaid. Saad Alhumaid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alhumaid, Saad, Woldesellassie M. Bezabhe, Mackenzie Williams, & Gregory M. Peterson. (2025). Trends in renal function testing in patients with dementia: a repeated cross-sectional analysis in Australian general practice. Journal of Nephrology. 38(7). 1855–1863.

Alhumaid, Saad, Woldesellassie M. Bezabhe, Mackenzie Williams, & Gregory M. Peterson. (2024). Prevalence and Risk Factors of Inappropriate Drug Dosing among Older Adults with Dementia or Cognitive Impairment and Renal Impairment: A Systematic Review. Journal of Clinical Medicine. 13(19). 5658–5658. 1 indexed citations

Tallei, Trina Ekawati, Fatimawali Fatimawali, İsmail Çeli̇k, et al.. (2023). 4’-fluorouridine as a potential COVID-19 oral drug?: a review. F1000Research. 11. 410–410. 1 indexed citations

Tallei, Trina Ekawati, Fatimawali Fatimawali, İsmail Çeli̇k, et al.. (2022). 4’-fluorouridine and its derivatives as potential COVID-19 oral drugs: a review. F1000Research. 11. 410–410. 2 indexed citations

Rabaan, Ali A., Saad Alhumaid, Hawra Albayat, et al.. (2022). Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review. Molecules. 27(16). 5335–5335. 16 indexed citations

Rabaan, Ali A., Muhammed A. Bakhrebah, Majed S. Nassar, et al.. (2022). Suspected Adenovirus Causing an Emerging HEPATITIS among Children below 10 Years: A Review. Pathogens. 11(7). 712–712. 11 indexed citations

Rabaan, Ali A., Saad Alhumaid, Abbas Al Mutair, et al.. (2022). Application of Artificial Intelligence in Combating High Antimicrobial Resistance Rates. Antibiotics. 11(6). 784–784. 70 indexed citations

Hajissa, Khalid, Mohmed Isaqali Karobari, Sonu Acharya, et al.. (2022). The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development. Vaccines. 10(8). 1346–1346. 5 indexed citations

Choudhary, Om Prakash, Priyanka Choudhary, Hitesh Chopra, et al.. (2022). Reverse zoonosis and its relevance to the monkeypox outbreak 2022. New Microbes and New Infections. 49-50. 101049–101049. 24 indexed citations

10.

Rabaan, Ali A., Muhammed A. Bakhrebah, Mohammed Garout, et al.. (2022). Global Prevalence of Colistin Resistance in Klebsiella pneumoniae from Bloodstream Infection: A Systematic Review and Meta-Analysis. Pathogens. 11(10). 1092–1092. 43 indexed citations

11.

Dinesh, M., Manish Dhawan, Ruchi Tiwari, et al.. (2022). Prophylactic and therapeutic insights into trained immunity: A renewed concept of innate immune memory. Human Vaccines & Immunotherapeutics. 18(1). 2040238–2040238. 20 indexed citations

12.

Rabaan, Ali A., Abbas Al Mutair, Mohammed Aljeldah, et al.. (2022). Genetic Variants and Protective Immunity against SARS-CoV-2. Genes. 13(12). 2355–2355. 3 indexed citations

13.

Hossain, Md. Jamal, Ali A. Rabaan, Abbas Al Mutair, et al.. (2022). Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines. Human Vaccines & Immunotherapeutics. 18(1). 2027197–2027197. 9 indexed citations

14.

Rabaan, Ali A., Muhammed A. Bakhrebah, Saad Alhumaid, et al.. (2022). Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers. 14(22). 5595–5595. 27 indexed citations

15.

Fatimawali, Fatimawali, Saad Alhumaid, Hawra Albayat, et al.. (2022). Designing an Epitope-Based Peptide Vaccine Derived from RNA-Dependent RNA Polymerase (RdRp) against Dengue Virus Serotype 2. Vaccines. 10(10). 1734–1734. 3 indexed citations

16.

Naveed, Muhammad, Urooj Ali, Ali A. Rabaan, et al.. (2022). Execution and Design of an Anti HPIV-1 Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses: An Immunoinformatic Approach. Vaccines. 10(6). 869–869. 23 indexed citations

17.

Dhama, Kuldeep, Firzan Nainu, Andri Frediansyah, et al.. (2022). Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. Journal of Infection and Public Health. 16(1). 4–14. 144 indexed citations breakdown →

18.

Koritala, Thoyaja, Vishwanath Pattan, Raghavendra Tirupathi, et al.. (2021). Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review. Infezioni in Medicina. 29(4). 495–503. 15 indexed citations

19.

Koritala, Thoyaja, Raghavendra Tirupathi, Ali A. Rabaan, et al.. (2021). A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy. Infezioni in Medicina. 29(3). 339–344. 30 indexed citations

20.

Rabaan, Ali A., Shamsah H. Al-Ahmed, Mohammed Garout, et al.. (2021). Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens. 10(5). 565–565. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact